PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK and SRG
16-Apr-2024 Amerigo Scientific’s GC Capillary Columns Enable Exceptional Analytical Performance Amerigo Scientific
15-Apr-2024 Naobios and Sumagen sign exclusive partnership to develop HIV vaccine  Andrew Lloyd Associates
13-Apr-2024 CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity CD Formulation
13-Apr-2024 CD Formulation Enables Efficacy Evaluation of Oral Thin Films: Ensuring Therapeutic Efficacy and Safety CD Formulation
12-Apr-2024 Macomics Unveils its Lead First-in-Class Anti-Pan-LILRB Monoclonal Antibody Programme with Positive Pre-clinical Data Presented at AACR 2024 Macomics
12-Apr-2024 SaniSure accelerates drug speed to market with Fill4Sure launch Sanisure
12-Apr-2024 Alfa Chemistry: Enhancing Thin Layer Chromatography (TLC) Capabilities with New Derivatization Reagents Alfa Chemistry
12-Apr-2024 Alfa Chemistry Provides an Abundance of Colloidal Nanoparticles for Research Alfa Chemistry
11-Apr-2024 ROM InWest invests €1.5 million into AI and computer vision company Kepler Vision Technologies Kepler Vision Technologies
11-Apr-2024 EFA Technologies, pioneer in portable blood labs, enters Brazilian market after Anvisa approval of its portable RevDx device EFA Technologies
11-Apr-2024 TILT Biotherapeutics Presents Clinical Data on TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer at AACR 2024 TILT Biotherapeutics
11-Apr-2024 SPT Labtech Appoints Rob Walton as New Chief Executive Officer SPT Labtech
11-Apr-2024 4SC: Landmark RESMAIN study data presented at the 5th World Congress of Cutaneous Lymphomas 4SC AG
11-Apr-2024 Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate combined with immune checkpoint inhibitors Andrew Lloyd Associates
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
10-Apr-2024 Axoltis Pharma receives authorization to launch SEALS – phase II clinical trial for ALS patients with drug candidate NX210c Andrew Lloyd Associates
09-Apr-2024 Green Elephant Biotech expands sustainable 96-well plate line for light-sensitive experiments Green Elephant Biotech
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc
09-Apr-2024 Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors Mestag Therapeutics